Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management

Hepatology International(2020)10.1007/s12072-020-10048-8Source: DataRank Database

Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management is a research paper published in Hepatology International (2020). On theSindex it has a DataRank of 0. It has been cited 64 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

64 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.15)OA: closedTopics (49)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Kee Seang Chew ORCID,Ruey Terng Ng ORCID,Karim El Kasmi,Ronald J. Sokol ORCID,Way Seah Lee ORCID

Live enrichment

PubMed:32356227 OpenAlex:https://openalex.org/W3023919005

NIH

Grant: UL1TR002535

National Institutes of Health

Grant: 3UL1TR002535-03S1

NIH Prior Approval Process Professional

National Institutes of Health

Grant: 5T32DK067009-13

Institutional Training Grant in Pediatric Gastroenterology

National Institutes of Health

Grant: 5U01DK062453-03

Etiology and Treatment of Biliary Atresia and INH

FWCI

4.15

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

closedLicense: Springer TDM

publisherhttps://link.springer.com/content/pdf/10.1007/s12072-020-10048-8.pdf

publisherhttps://link.springer.com/article/10.1007/s12072-020-10048-8/fulltext.html

journalhttps://doi.org/10.1007/s12072-020-10048-8

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32356227

https://dx.doi.org/10.1007/s12072-020-10048-8

Fields of Study

Clinical Nutrition and GastroenterologyPediatric Hepatobiliary Diseases and TreatmentsInfant Nutrition and Health03 medical and health sciences0302 clinical medicineFat Emulsions, IntravenousHumansIntestinal DiseasesLiver DiseasesMalabsorption SyndromesParenteral NutritionPatient Care ManagementShort Bowel SyndromeSoybean Oil

MeSH Terms

Fat Emulsions, IntravenousHumansIntestinal DiseasesLiver DiseasesMalabsorption SyndromesParenteral NutritionPatient Care ManagementShort Bowel SyndromeSoybean Oil

Keywords

MedicineEnteral administrationLiver diseaseParenteral nutritionIntensive care medicineIntestinal failureShort bowel syndromeCholestasisInternal medicineHepatologyGastroenterologyFat Emulsions, IntravenousIntestinal DiseasesMalabsorption SyndromesLiver DiseasesHumansPatient Care ManagementSoybean OilFish oil-based lipid emulsionGut–lipid–liver axisIntestinal failure-associated liver diseaseLiver fibrosisParenteral nutrition-associated cholestasisSmall bowel bacterial overgrowthSoy-based intravenous lipid emulsionStigmasterol

Sustainable Development Goals

SDG 3: 3. Good health

Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management

FAIR Checklist

Authors (5)

Funding (4 grants)

Impact

Open Access

Topics